131 related articles for article (PubMed ID: 10704894)
21. Solid-state NMR investigation of indomethacin-cyclodextrin complexes in PEG 6000 carrier.
Wulff M; Aldén M; Tegenfeldt J
Bioconjug Chem; 2002; 13(2):240-8. PubMed ID: 11906261
[TBL] [Abstract][Full Text] [Related]
22. The effect of 2-hydroxypropyl-beta-cyclodextrin on in vitro drug release of steroids from suppository bases.
Usayapant A; Iyer BR
Drug Dev Ind Pharm; 1999 Mar; 25(3):387-90. PubMed ID: 10071835
[TBL] [Abstract][Full Text] [Related]
23. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
24. Improvement by adjuvants on the rectal bioavailability of non-absorbable drugs following administration of suppository.
Nakanishi K; Masada M; Nadai T
J Pharmacobiodyn; 1990 Dec; 13(12):760-5. PubMed ID: 2098548
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
Samy AM; Marzouk MA; Ammar AA; Ahmed MK
Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
[TBL] [Abstract][Full Text] [Related]
26. Thermal and rheological study of lipophilic ethosuximide suppositories.
Victoria MM; David CJ
Eur J Pharm Sci; 2003 Jun; 19(2-3):123-8. PubMed ID: 12791414
[TBL] [Abstract][Full Text] [Related]
27. Solid state studies of drug-cyclodextrin inclusion complexes in PEG 6000 prepared by a new method.
Wulff M; Aldén M
Eur J Pharm Sci; 1999 Aug; 8(4):269-81. PubMed ID: 10425377
[TBL] [Abstract][Full Text] [Related]
28. Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration.
Appelbaum SJ; Mayersohn M; Dorr RT; Perrier D
Cancer Chemother Pharmacol; 1982; 8(1):93-8. PubMed ID: 7094203
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
[TBL] [Abstract][Full Text] [Related]
30. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of mucin as a release enhancer for rectal delivery of glibenclamide.
Adikwu MU; Okafor JO
Curr Drug Deliv; 2006 Jul; 3(3):243-54. PubMed ID: 16848726
[TBL] [Abstract][Full Text] [Related]
32. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits.
Watanabe Y; Matsumoto Y; Seki M; Takase M; Matsumoto M
Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3042-7. PubMed ID: 1477920
[TBL] [Abstract][Full Text] [Related]
33. Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers.
Emara LH; Badr RM; Elbary AA
Drug Dev Ind Pharm; 2002 Aug; 28(7):795-807. PubMed ID: 12236065
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of fenoterol hydrobromide suppositories.
Ghorab D; Refai H; Tag R
Drug Discov Ther; 2011 Dec; 5(6):311-8. PubMed ID: 22466443
[TBL] [Abstract][Full Text] [Related]
35. New Formulation and Evaluation of Camptothecin Encapsulated and/or Dispersed Suppository.
Fatmi S; Taouzinet L; Lahiani-Skiba M; Skiba M; Iguer-Ouada M
Anticancer Agents Med Chem; 2021; 21(9):1183-1190. PubMed ID: 32885761
[TBL] [Abstract][Full Text] [Related]
36. Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats.
Nagarsenker MS; Meshram RN; Ramprakash G
J Pharm Pharmacol; 2000 Aug; 52(8):949-56. PubMed ID: 11007065
[TBL] [Abstract][Full Text] [Related]
37. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
Szente L; Apostol I; Gerlóczy A; Szejtli J
Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
[TBL] [Abstract][Full Text] [Related]
38. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
[TBL] [Abstract][Full Text] [Related]
39. Ketoprofen suppository dosage forms: in vitro release and in vivo absorption studies in rabbits.
Babar A; Bellete T; Plakogiannis FM
Drug Dev Ind Pharm; 1999 Feb; 25(2):241-5. PubMed ID: 10065359
[TBL] [Abstract][Full Text] [Related]
40. Biopharmaceutical characteristics of a suppository base containing poly (oxyethylene)-poly (oxypropylene) copolymer, Unilube. I. Effects of a suppository base containing Unilube 70DP-950B on release and rectal absorption of aminopyrine in rabbit.
Itoh S; Morishita N; Yamazaki M; Suginaka A; Tanabe K; Sawanoi M
J Pharmacobiodyn; 1987 Apr; 10(4):173-9. PubMed ID: 3656064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
